Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Metabolic control seen in high-fat diet-fed mice by a novel hybrid peptide

Oct. 9, 2018

Amicus and University of Pennsylvania establish gene therapy collaboration

Oct. 9, 2018

Zafgen presents interim analysis results from phase II study of ZGN-1061

Oct. 9, 2018

Pancreatic islet cells express "innate immune" protein

Oct. 9, 2018

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

FDA approves Tegsedi to treat polyneuropathy of hATTR in adults

Oct. 8, 2018

First phase II results presented for LY-3298176 in patients with type 2 diabetes

Oct. 8, 2018

Hepato-preferential insulin analogue protects dogs from hypoglycemia

Oct. 8, 2018

KINGS mouse as a novel preclinical model of diabetes

Oct. 8, 2018

Alnylam reports phase I/II data on lumasiran in PH1, initiates phase III trial

Oct. 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...